Mary Ann Gray - 10 Dec 2021 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Mary Ann Gray
Issuer symbol
SRPT
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
14 Dec 2021, 19:02:30 UTC
Previous filing
10 Feb 2022
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $0 +967 +11% $0.000000 9,403 10 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Restricted Stock Units Options Exercise $0 -967 -100% $0.000000* 0 10 Dec 2021 Common Stock 967 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.
F2 The third out of three annual equal installments of restricted stock units vested on December 10, 2021.